Patents
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
06/2002
06/19/2002CN1354747A 2-amino-4H-3.1-benzoxazinone-4-keto derivatives for treatment of obesity
06/19/2002CN1086430C Method of optically brightening polyamides
06/19/2002CN1086389C Isoesperamicin and its synthesizing process
06/19/2002CN1086387C N-(aryloxyalkyl)heteroarylpiperidines and heteroarylpiperazines, their preparing method and their use as medicine
06/18/2002US6407285 Intermediates for making HIV-protease inhibitors and methods for making HIV-protease inhibitors
06/18/2002US6407255 Chemical synthesis of 1,2,4-triazolinone derivative
06/18/2002US6407233 Halogen pyrimidines and its use thereof as parasite abatement means
06/18/2002US6407106 For therapy of inflammatory disturbances of the gastrointestinal tract
06/18/2002US6407101 Progesterone receptor antagonists; contraceptives, hormone replacement therapy; breast and prostate cancer treatment; menopause
06/18/2002US6407098 3-(carboximino)-1,4,2-oxathiazine derivatives; pesticides
06/18/2002US6407094 Glutamate receptor antagonists
06/18/2002US6407087 UCF116 derivatives
06/18/2002US6407041 Substituted 2,4-diamino-1,3,5-triazines
06/18/2002CA2238140C Imidazole, triazole and tetrazole derivatives
06/18/2002CA1341370C Fused polycyclic compounds, methods of manufacture, and their use as paf antagonists, antihistamines and/or antiinflammatory agents
06/13/2002WO2002046181A2 Abca-1 elevating compounds against coronary artery disease or atherosclerosis
06/13/2002WO2002046172A2 Substituted 1, 3, 5-triazines and pyrimidines as abca-1 elevating compounds against coronary artery disease or atherosclerosis
06/13/2002WO2002046171A2 Anilinopyrimidine derivatives as ikk inhibitors and compositions and methods related thereto
06/13/2002WO2002046170A2 Anilinopyrimidine derivatives as jnk pathway inhibitors and compositions and methods related thereto
06/13/2002WO2002046166A1 Phenylethenyl or phenylethinyl derivatives as glutamate receptor antagonists
06/13/2002WO2002046162A1 Ortho-substituted nitrogen-containing bisaryl compounds used as potassium channel inhibitors
06/13/2002WO2002046151A1 Delta 1-pyrrolines used as pesticides
06/13/2002WO2002046150A2 Compounds which mimic the chemical and biological properties of discodermolide
06/13/2002WO2002046141A2 Coumpounds of the formula r1-x-y-z-nr2r3 as abca-1 elevating agents against coronary artery disease or atherosclerosis
06/13/2002WO2002046129A2 Inhibitors of histone deacetylase
06/13/2002WO2002045652A2 Tyrosine kinase inhibitors
06/13/2002WO2002020011A3 A method for treating allergies using substituted pyrazoles
06/13/2002WO2002018353A3 Oxazolidinone chemotherapeutic agents
06/13/2002WO2002014315A3 Substituted pyrazoles
06/13/2002WO2002008222A3 HETEROARYL-β-ALANINE DERIVATIVES AS ALPHA 4 INTEGRIN INHIBITORS
06/13/2002WO2002000651A3 Factor xa inhibitors
06/13/2002WO2001098277A3 Substituted bicyclic derivatives for the treatment of abnormal cell growth
06/13/2002WO2001096330A3 Thrombin receptor antagonists
06/13/2002US20020072616 3-azabicyclo[3.1.0]hexane derivatives useful in therapy
06/13/2002US20020072603 Novel IL-5 inhibiting 6-azauracil derivatives
06/13/2002US20020072519 Useful as psychotherapeutic agents
06/13/2002US20020072518 Bicyclic alphavbeta3 antagonists
06/13/2002US20020072517 Substituted cyclic amine metalloprotease inhibitors
06/13/2002DE10041671C1 Verfahren zur Herstellung von Imidazo[1,2-c][2,3]benzodiazepinen sowie Phenylessigsäureester und Oxazol-Derivate als Zwischenprodukte bei deren Herstellung Benzodiazepines process for the preparation of imidazo [1,2-c] [2,3] oxazole and phenylacetic acid esters and derivatives, as intermediates in the preparation thereof
06/13/2002CA2436662A1 Abca-1 elevating compounds against coronary artery disease or atherosclerosis
06/13/2002CA2431045A1 Compounds which mimic the chemical and biological properties of discodermolide
06/13/2002CA2431005A1 Coumpounds of the formula r1-x-y-z-nr2r3 as abca-1 elevating agents against coronary artery disease or atherosclerosis
06/13/2002CA2430966A1 Anilinopyrimidine derivatives as jnk pathway inhibitors and compositions and methods related thereto
06/13/2002CA2430951A1 Substituted 1, 3, 5-triazines and pyrimidines as abca-1 elevating compounds against coronary artery disease or atherosclerosis
06/13/2002CA2430683A1 Delta 1-pyrrolines
06/13/2002CA2429728A1 Tyrosine kinase inhibitors
06/12/2002EP1213285A2 4,5-dipheny-oxazole derivatives and their use as platelet aggregation inhibitors
06/12/2002EP1212320A2 Phenylpiperazines as serotonin reuptake inhibitors
06/12/2002EP1212312A1 Novel derivatives of flavones, xanthones and coumarins
06/12/2002EP1212309A1 Caspase inhibitor
06/12/2002EP1212307A1 Unsaturated oxime ethers and the use thereof for control of harmful fungi and veterinary pests
06/12/2002EP1212304A2 Hypoglycemic sulfonyl pyrazolones and pyrazolines
06/12/2002EP1212303A2 Bicyclic androgen and progesterone receptor modulator compounds and methods
06/12/2002EP1212299A1 Substituted piperidine compounds useful as modulators of chemokine receptor activity
06/12/2002EP0984778B1 Neuropeptide-y ligands
06/12/2002EP0934080B1 1,3-bis-(n-lactamyl) propane and the pharmaceutical and cosmetic use thereof
06/12/2002EP0873320B1 Piperazine derivatives as tachykinin antagonists
06/12/2002EP0776324B1 Endothelin antagonists
06/12/2002EP0757986B1 Arylpiperidine and arylpiperazine derivatives and drugs containing the same
06/12/2002EP0734259B1 Use of piperidine compounds in the treatment of schizophrenia
06/12/2002CN1353709A Bicyclic oxazolidinones as antibacterial agents
06/12/2002CN1353699A Substituted bicyclic heterocycles, process for their preparation and their use as antiobesity and hypocholesterolemic agents
06/12/2002CN1353698A Novel morpholine derivatives, method for production thereof and pharmaceutical preparations containing said derivatives
06/12/2002CN1353695A Heterocyclically substituted benzimidazoles, production and application thereof
06/11/2002US6403799 Methods for the preparation of intermediates in the synthesis of HIV-protease inhibitors
06/11/2002US6403791 Treatment of inflammatory diseases or autoimmune diseases in humans or animals
06/11/2002US6403786 Compounds used to label, detect and sequence nucleic acids
06/11/2002US6403633 Useful antiangiogenic, antiarthritic, antiinflammatory, antirestenotic, antiinvasive, antimetastic, antiosteoporotic, antiretinopathic, contraceptive and tumoristatic treatment agents
06/11/2002US6403632 Cyclic amide derivative
06/11/2002US6403620 Inhibitors of factor Xa with a neutral P1 specificity group
06/11/2002US6403608 3-Substituted isoquinolin-1-yl derivatives
06/11/2002US6403595 Anticoagulants
06/11/2002US6403592 Serotonin reuptake inhibitors
06/11/2002US6403583 Anticoagulant agents for treatment and prevention of thromboembolic disorders.
06/11/2002US6403580 Having an inhibitory effect on signal transduction mediated by tyrosine kinases, the use thereof for treating diseases, particularly tumoral diseases, diseases of the lungs and respiratory tract, and the preparation thereof.
06/11/2002US6403577 Hexamethyleneiminyl tachykinin receptor antagonists
06/11/2002CA2169839C Antipsychotic method
06/06/2002WO2002044173A2 Herbicidal heterocycles
06/06/2002WO2002044166A1 Substituted quinolines as antitumor agents
06/06/2002WO2002044156A2 Benzimidazole derivatives useful as tie-2 and/or vegfr-2 inhibitors
06/06/2002WO2002044149A1 Indole and dihydroindole derivatives
06/06/2002WO2002044145A1 New mandelic acid derivatives and their use as throbin inhibitors
06/06/2002WO2002020474A3 Resorcinol derivatives
06/06/2002WO2001098296A3 2-(3,5-disubstituted-4-pyridyl)-4-(thienyl, thiazolyl or arylphenyl)-1,3-oxazoline compounds
06/06/2002US20020068833 Formed as enantiomers of cis-beta-phenylglycidic acid/beta-phenylisoserine react with nitrile compound via Ritter reaction
06/06/2002US20020068828 1,3-oxazoline and 1,3-thiazoline derivatives, their preparation, and their use as pesticides
06/06/2002US20020068740 Treatment of diabetic complications such as diabetic neuropathy, diabetic nephropathy, diabetic retinopathy, myocardial infarction, cataracts and diabetic cardiomyopathy.
06/06/2002US20020068737 Antagonists for human alpha 1a receptors; lowering intraocular pressure; inhibiting cholesterol synthesis; relaxing lower urinary tract tissue; treatment of benign prostatic hyperplasia, impotency, cardiac arrhythmia, etc.
06/06/2002US20020068735 Progesterone receptor antagonist; inhibiting breast, uterine, ovarian, endometrial, or prostate cancer
06/06/2002US20020068730 New amidino derivatives and their use as thormbin inhibitors
06/06/2002US20020068720 Containing s cyclodextrin compound in a concentration sufficient to maintain the drug in solution at such a drug concentration.
06/06/2002DE10060412A1 DELTA1-Pyrroline DELTA1-pyrrolines
06/05/2002EP1211251A1 Chromone derivatives, process for the preparation of the same and uses thereof
06/05/2002EP1211249A1 Novel thiazine or pyrazine derivatives
06/05/2002EP1211246A1 Pyrimidine derivatives and herbicides containing the same
06/05/2002EP1210345A1 Oxazole ppar antagonists
06/05/2002EP1210344A1 Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
06/05/2002EP1210343A2 Benzoic acid derivatives and their use as ppar receptor agonists
06/05/2002EP1210339A1 Benzoic acid derivatives for the treatment of diabetes mellitus
06/05/2002EP1210333A2 Novel herbicides